检索历史清除

首页> Leukemia: Official journal of the Leukemia Society of America, Leukemia Research Fund, U.K> Pretreatment of leukemic cells with low-dose decitabine markedly enhances the cytotoxicity of gemtuzumab ozogamicin

Pretreatment of leukemic cells with low-dose decitabine markedly enhances the cytotoxicity of gemtuzumab ozogamicin

导出原文传递

翻译打印收藏纠错

作者： Kurimoto,M. ^[1] ; Matsuoka,H. ^[2] ; Hanaoka,N. ^[3] ; Uneda,S. ; Murayama,T. ; Sonoki,T. ; Nakakuma,H.

作者单位： Department of Hematology, Hyogo Cancer Center, Akashi, Japan ^[1] Department of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan ^[2] Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Graduate School of ^[3]

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交